Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Prostatic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Breast Neoplasms 4Stomach Neoplasms 3Neoplasms 3Esophageal Neoplasms 3Pancreatic Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colorectal Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pitfalls of PET Scan on Pediattic 1Pathologic Complete Response 1Ovarian Neoplasms 1Nasopharyngeal Neoplasms 1Myocarditis 1Multiple Pulmonary Nodules 1Mouth Neoplasms 1Metastasis of Unknown Origin 1Meningioma 1Lymphoma, B-Cell 1Lymphatic Metastasis 1Intraabdominal Infections 1Hematologic Neoplasms 1Gynecological Tumors 1

Interventions

vandetanib 1Positron Emission Tomography Computed Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Aggression × Positron Emission Tomography Computed Tomography × Clear all
NCT02633111 2025-11-04

DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas

Memorial Sloan Kettering Cancer Center

Active not recruiting
501 enrolled
Lymphoid

Aggression, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡